E2F2, E2F transcription factor 2, 1870

N. diseases: 75; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.040 AlteredExpression phenotype BEFREE More importantly, circPVT1 was predominantly abundant in the cytoplasm of NSCLC cells, and circPVT1 could serve as a competing endogenous RNA to regulate E2F2 expression and tumorigenesis in a miR-125b-dependent manner, which is further verified by using an in vivo xenograft model. 30537738 2018
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.040 GeneticVariation phenotype BEFREE Because E2F transcription factor 2 (E2F2) promoter polymorphisms have been implicated in carcinogenesis and prognosis, we investigated associations between genetic variants in five E2F2 promoter polymorphisms and recurrence risk of squamous cell carcinoma of the oropharynx (SCCOP) in 1 008 patients. 27864908 2017
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.040 GeneticVariation phenotype BEFREE We concluded that E2F1 and E2F2 genetic variants may jointly play important roles in head and neck carcinogenesis. 22344756 2012
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.040 Biomarker phenotype BEFREE The enhanced early onset of tumors seen in the absence of E2F2 coincides with an expansion of immature B lineage cells that are likely to be the target for Myc oncogenesis. 19749980 2009